Abstract. Two processes are incorporated into a new model for transmissi These are general incidence for the lengthening process of infectious polym converting noninfectious monomers, and the joining of two polymers to for The model gives rise to a system of three ordinary differential equations, whi threshold behavior dependent on the value of the parameter combination givin tion number 1Zo. For Ko < 1, infectious polymers die out, whereas for Kq > asymptotic to a positive disease equilibrium. The effect of both general inci decrease the equilibrium value of infectious polymers and to increase the equili monomers. Since the onset of disease symptoms appears to be related to the polymers, both processes may significantly inhibit the course of the disease. W the equilibrium distribution of polymer lengths is obtained and shows a sharp to the distribution resulting from mass action incidence. Qualitative global resu and disease equilibria are proved analytically. Numerical simulations using p experiments on mice (reported in the literature) provide quantitative demonstr these two processes.
1. Introduction. Prion diseases, though widely studied at many levels, continue to challenge understanding. A prion is an infectious protein. Several prion diseases are known, or suspected, to be transmissible, both via ingestion and iatrogenically; as a group, they are thus referred to as transmissible spongiform encephalopathies (TSEs). Examples include scrapie, which affects sheep and goats; bovine spongiform encephalopathy (BSE), which affects cows; chronic wasting disease (CWD), which affects mule deer and elk; and variant Cruetzfeldt-Jakob disease (vCJD), which affects humans [8, 9] . Additionally, mice and hamsters in laboratory experiments can be infected with scrapie [30] .
Though incidence of vCJD in humans has declined to just a few new cases per year [36] and BSE incidence also appears to be declining [23] , prion diseases warrant ongoing study for reasons that include the following. First, there may be previously unrecognized routes of infection: new research shows that prions can bind to some soils and cause infection via inoculation with those soils [17] , indicating that graz-ing animals may acquire TSEs despite having safely prepared feed. Seco are extremely difficult to destroy, remaining infective despite heat or ra would inactivate other known infectious agents [1, 5] . Third, prion replic a new frontier in scientific understanding: protein-only replication canno nucleic acids, but must occur somehow for TSEs to spread. Comprehendi replication works may provide great insight to other biological processes.
A specific naturally occurring protein is vulnerable to infection by p therefore known as prion protein. In its noninfectious form prion protei by PrPc, and in its infectious form it is denoted by PrPSc; see, for exa for discussion of this notation. The forms differ only in the folding of [27] . Humans, cows, sheep, and other animals susceptible to TSEs pr normally [4] . There is evidence both that an accumulation of PrPSc may [24, 21] and that a lack of PrPc may leave the brain overly susceptible to Either or both of these may lead to symptoms associated with TSEs. In transmissible prion disease, some portion of PrPSc is introduced into the this PrPSc can cause more infectious protein to be made. Though the mec such protein replication is not fully understood, nucleated polymerization candidate [15, 18] .
Nucleated polymerization involves PrPSc attaching to PrPc and conver prpSc \Ymje proteins usually exist as individual units, also known as m it appears that PrPSc benefits from aggregating in some way [11, 16] . A confers greater stability, and may even be necessary to maintain the alt tein folding. We assume within this paper that these aggregates have a l [18, 26] , and we typically refer to the aggregates as polymers. In our nuc merization model, each polymer may attach at either end to a PrPc monom converting it to the infectious form of PrPSc. Since the polymer has th its length by one unit of protein, we refer to this process as lengthening polymerization also involves polymer splitting. We assume a minimum via length, so that when polymer splitting results in pieces below the minim these pieces must break apart into their component units of PrPc. Addit model includes polymer joining, in which two PrPSc polymers join togeth one longer polymer.
Models of nucleated polymerization for PrPc monomers and PrPSc p containing a discrete number of monomers are formulated and analyzed [22] . Based on these, a model with continuous polymer length is introd and further analyzed in [12, 14, 28] . All these models assume mass action incid the lengthening process of infectious polymers attaching to PrPc units. W this form of incidence in a way that reduces lengthening when the total infectious protein becomes large in proportion to the number of polym research [24] has indicated that only truncated forms of polymers are able to this way; it is also possible that polymers within a specific range of lengt to lengthen at the fastest rate, but that all polymers are capable of lengt Our general incidence term captures these features by reducing the rate of le when total PrPSc mass is large relative to the total number of PrPSc poly is, we reduce the rate of lengthening as the average polymer length becom In addition, our model is the first to include polymer joining. Joining is the fact that large fibrils or aggregates of PrPSc are observed in late stag [2, 10] .
We start in section 2 by incorporating the processes of general incidence and polymer joining into an ordinary differential equation (ODE) for the number of monomers, coupled with a partial integrodifferential equation for the density of polymers depe ing on polymer length. Under some assumptions, this system is converted to a syste of three ODEs, which is analyzed in section 3. Numerical simulations for param obtained from experimental data on mice [30] are presented in section 4, and conclude in section 5 with a discussion.
2. Model formulation. A core model of nucleated polymerization exists in [12, 13, 14, 28] with some extensions in [32] . We continue to use the same variables and parameters and introduce two new parameters, u and r/, to account for general incidence and polymer joining, respectively:
• V(t) is the number of PrPc monomers at time t\ • u(x, t) is the density of PrPSc polymers of length x at time t;
• xo is the lower bound for polymer length; that is, polymers have length x with xo < x < oo; • U(t) = f™ u(x, t)dx is the number of PrPSc polymers at time t\
• p(t) = f™ xi/(x, t)dx is the number of PrPSc monomers comprising polymers at time t]
• W(t) = P(t) -xoU(t) is the number of PrPSc units not accounted for within the minimal polymer lengths; • A is the source rate for naturally produced PrPc monomers; • 7 is the metabolic degradation rate for PrPc; • r is a rate associated with lengthening of PrPSc polymers by attaching to and converting PrPc monomers; • uj is a parameter associated with polymer lengthening; • /?(x) is the length-dependent rate of polymer breakage; • k(x, y) is the probability, when a polymer of length y breaks, that one of the two resulting polymers has length x; • /x(x) is the length-dependent metabolic degradation rate of PrPSc polymers; • rj is the rate at which PrPSc polymers join together. All parameters are assumed to be positive with the exception of u and 77, which may also be zero.
2.1. PDE model. Our model, incorporating both general incidence and polymer joining into the model formulated and discussed in [12, 13, 14, 28] , has monomer dynamics governed by (2.1) V'(t) = \-<yV(t)-1 + " u)P(t) )>+2 Jo x JXo P(y)K(x,y)u(y,t)dydx 1 + u)P(t) Jo JXo with V'(t) = ^, and polymer dynamics given by rV(t) f°° rx y.00 (2.2) + 77 / u(x -y, t)u(y, t)dy -2t?u(x, t) I u(y, t)dy, subject to nonnegative initial conditions and the boundary condition (2. 3) u(xo,0=0.
We write the polymer lengthening Note that in the case u = 0 this is a large there is a saturation effect, with the result that less lengthenin This matches the in vitro observations of [24, 31] .
The polymer joining term r\ f* u(x -y, t)u(y, t)dy introduces the join eter 77 and indicates that a new polymer of length x results from th smaller polymers of lengths x -y and y. Note that the upper integrat written as x or x -xq with identical results, as there are zero polyme than xq. Changing the form of the integration limit does not affect model. The last term 2r]u(x, t) /^° u(y, t)dy describes the loss of a po x when it joins with another polymer, of any length, to create a la Symmetry mandates the factor 2.
Note that with mass action incidence and no polymer joining, i.e 7/ = 0, our model reduces to that in [12, 13, 14, 28] . For this case, bounded (3(x), /x(x), and a general kernel n(x,y) is analyzed in [32] .
Conversion to ODEs. Under an assumption of equidistribu
a system of three ODEs in V, £/, and P can be obtained from (2.1) an tributed splitting means that splitting is equally likely wherever two pro joined together; hence the splitting rate (3(x) is proportional to polymer l We make the additional assumption that polymer metabolic degra at a constant rate, i.e., /x(x) = //. A form of the PDEs that assume and no polymer joining was converted to ODEs in [28] by integr integrating the product of x and (2.2), over [a:0, 00). Proceeding simila incidence term is independent of x and converts analogously. The j f™u(x,t)f™u(y,t)dydx simplifies to U2(t). The remaining joining (2.2) gives poo px /.00 px-xo 
The compartmental diagram of this system appears in Figure 1 .
3. Model analysis.
3.1. Nondimensionalization. To facilitate analysis, rewrite the ODE system (2.5) in a nondimensionalized form. Let a = /i 4-(3xq and T = at. Rewrite U(t) = *X(T), V(t) = £Ty{T), and W(t) = fTZ(T). Define a = &£, p = a, 6 = &*, f=^, and<A=f. Then X' = Z-X-<j)X2, 1 + v\Z + oA; ) with #' = ^ . The nondimensionalization process reduces the number of parameters from eight to five. Note that 8 = J^*^_ G (0, 1). Setting v = 0 simplifies the incidence term to mass action, whereas setting 0 = 0 simplifies the model to the case with no polymer joining.
In all that follows, disease is assumed to be initially present; thus the nonnegative One technique [37] examines the infective compartments, in this case the equations within (3.1) for X and Z. The Jacobian J of the (X,Z) system about the DFE is apportioned into two matrices F and G such that J = F -G, where F contains all elements resulting from new infections and G contains all remaining movement between compartments. Then 1Z0 is the spectral radius of the matrix FG~l. For the model given in (3.1),
and the spectral radius of FG~l is ^. Hence 1Z0 = |. The next result follows from Theorem 2 of [37] .
Lemma 3.2. IfH0 < 1, then the DFE of (3.1) is locally asymptotically stable; if Uq > 1, then the DFE is unstable.
In the biological variables,
<32) k-W^W'
The same 7£0 results from the model of nucleated polymerization in wh ening mechanism proceeds according to mass action and polymer jo occur [28] . This result makes it clear that general incidence and joinin the potential success of infection via nucleated polymerization. How later, the inclusion of a generalized incidence term and polymer join the distribution of polymer lengths as time progresses during disea disease equilibrium. In order to use the comparison theorem to show that the DFE of sys GAS, it is required that p > 1 in Theorem 3.4. Next we apply the Liapu to establish that the DFE is GAS without assuming that p > 1 but at required to be less than 1 -62. Lemma 3.6. IfH0 > 1, then system (3.1) has a uniqu mat that tsb EE ?«j is given nivpn hn 0y ( (X X* ,y V* ,£ 7*\ ) --mat that tsb EE is ?«j given nivpn 0y hn (X ( X* ,y V* ,£ 7*\ ) --^px/(1+6)+r(1_^), a~p pl/(1+6)+(1_6i}, pi/{1+S)+(i-6*) g-p ) -IfU0<l, then (3.1) has no EE.
Proof If (j) > 0, then system (3.1) cannot be solved explicitly for the EE. However, for 4> > 0, at equilibrium, Z and y can be expressed in terms of X by Z = X + <$>X2, (3.7) + [pu{\ +6)+ p<t>{\ -6) + (1 -<52)] * + p -a.
Since the first three coefficients of (3.7) are positive and the constant term is negative for 1Zo > 1, there is a unique positive root. The expressions in (3.6) show that unique positive equilibrium values for y and Z result from the unique positive X\ hence there is a unique EE (X*,y\Z*) for Uq > 1. If 0 = 0, then the solution of (3.7) is given explicitly as X* = pi/(l^)~/(i-6^)^ givinS ^* and Z* from (3.6) as in the lemma statement. If TIq < 1, then (3.7) has no positive root, and hence there is no EE. D The proof of the following result is standard, using the Routh-Hurwitz conditions. For details, see Appendix A.
Theorem 3.7. IfUo > 1, then the unique EE of system (3.1) is locally asymptotically stable. Proof. Consider the equivalent system {X,Z,y + Z) of (3.1), namely (3.4). Th equivalent system's matrix of partial derivatives has the sign pattern " -+ 0 " + -+ in the case when p > 1 (where * is + o tive system. Then by Theorems 2.3.2 and [33] , the system exhibits monotone dyna equilibrium. □
The system equivalent to (3.1) has only two possible equilibria: the DFE (0, 0, and the EE {X*,Z*,y* + Z*) from Lemma 3.6. If 1ZO > 1, then by Lemma 3.2, the DFE is unstable, and by Theorem 3.7, the EE is locally asymptotically stable. The facts together with numerical simulations (see section 4) indicate that the EE is G if 72,o > 1 and p > 1, but we do not have a proof.
A Liapunov function argument is used in section 3.4 of [28] to prove a global asymptotic stability result in the case u = 7? = 0.
3.5. Effects of v and <f> on the EE. The nucleated polymerization model with mass action and without polymer joining has been well studied in earlier work [12, 13, 14, 28] . It is useful to understand the effects of positive values of v and <j> on the EE of model (3.1). By taking partial derivatives of (3.6) and (3.7) and using parameter relationships at the EE, the following signs are determined. (For selected details, see Appendix B.) Proposition 3.9. At the EE of (3.1), for Hq > 1, ^ < 0, ^ > 0, and We can also interpret the results in terms of P (the number of PrPSc monomer units comprising the polymers) from (2.4). At the DFE, P = 0, and at the EE, P* = W* + XoU*. By adding the second and third equations in (2.4), it follows that ^-< 0 and ^^ < 0 at the EE. The ratio ^ gives the mean polymer length.
Dividing the last equation of (2.4) by U and differentiating with respect to 77, it is seen that ^(^-) > 0 at the EE.
3.7. A solution of the PDE system in the case of general incidence. Returning to (2.1) and (2.2), consider the case of general incidence but no joining, i.e., rj = 0. The corresponding system of ODEs given in system (2.4 7/ = 0, has EE from Lemma 3.6 given by the following: To find an equilibrium distribution of polymer lengths, set J^u(x, Compute the derivative with respect to x of the rest of (2.2), subst of U*,V*, and P* from (3.8) to obtain
The boundary condition u(x0) = 0, first given in (2.3), can be used to to (3.9) of the form (3.10) u(x) = Ce W'o+i*)* (z-zo)(/?z + /3xo + 2^).
Note that from (2.2) with x = xo, (3.11) |Wl)] = W.(il^l).
Substitute into (3.11) values of £/*, V*, and P* from (3.8). Then compute the derivative of (3.10) and set it equal to (3.11) to find /?3(/?AT-7(/?*o + /i)2) (0xo + /i)3(2/3x0 + /i)ky03xo + A*)2 + /*/?r The equilibrium solution from (3.10), denoted by ti* / fl(«-«n)(fl«+fl*o+3/o\ /33(x -xQ)(/3x -h /3x
where 7^0 is given in (3.2). Note that the numerato Hq > 1. The denominator of u*(z) shows that an incre of polymers of length x at steady state for all viable Prom (3.10), it can be seen that the value of x at w mum is independent of u and is given by (3.13) x = (VS -1)^ + VZx0
However, from (3.12), the magnitude of this maxim 4. Numerical simulations. To complement the previous analytical results, w present some numerical simulations. All simulations shown, unless otherwise n use the same parameters as in [14] , namely xq = 6/(SAF/sq), A = 4400/day 5/day, r = 0.3/(SAF/sq * day), \i = 0.04/day, and 0 = 10"4(SAF/sq)/day, g p«2x 105 > 1. These parameters follow from data and observations in [3, 7 25, 30] . Some broader ranges include that x0 « 6-30 [20] , PrPc has a half-li 3-6 hours [3, 7, 25] and hence 7 « 3-5/day, \x < 7 [20, 25] , and A » 103-104 [20] . The units SAF/sq are a measure of scrapie-associated fibrils counted in sple Compton white mice that had been given intracerebral injections of the 139A sc strain [30] . Note that the above parameter set gives 7£o » 16. We vary values and rj to investigate the changes introduced by these parameters.
First consider general incidence. The effects of the parameter u on £/, V , an discussed in section 3.6, are shown in Figure 2 . Additionally, the equilibrium sol for u(x) found in (3.12) allows a comparison of steady-state polymer distribut given differing values of u. This appears in Figure 3 , computed from (3.12). N that, for all values of a;, the maximum value of u(x) occurs at x « 303, as can computed from (3.13).
Next consider joining. Section 3.6 describes the effects of 77 on the EE of sy (2.4), shown numerically in Figure 4 . As discussed in section 3.6, the sign of @£ undetermined; hence the sign of ^-p is also undetermined. It turns out that m parameter combinations, but not all, support ^-< 0. The opposite can occur in case that 6 -♦ 1, which is possible in the case that /x is small or (3xo is large. A brief explanation appears in Appendix C. Even so, it appears that ^-> 0 for only small values of (f). This effect is demonstrated in Figure 5 for ^^ , which is proportional to ^-> 0. The parameters used in Figure 5 are the same as those listed above, but with smaller /i, namely \i = 0.02, and u = 0.
Last, combine general incidence with joining. Lemma 3.2, Theorem 3.7, and Remark 3.8 together suggest that the EE of system (3.1) is GAS. Numerical simulations such as those shown in Figure 6 support this suggestion. The pair of surfaces in this figure show long-term equilibrium values of U and P, denoted C/qq and P^, as both u and 77 vary. For all shown pairs of u) and rj values, both Uqq and P^ remain positive, indicating (as a consequence of Remark 3.8) that they correspond to U* and P*. The shown ranges for u and rj correspond to the lower range of values used in Figures 2, 3, 4 , and 5. Similar graphs generated using higher values of lj and rj also result in positive values of £/qo and Poo-The parameter values used for xo, A, 7, r, /i, and /? are the same as those given at the beginning of this section. 5. Biological interpretation and discussion. We now discuss the analytical results and numerical simulations (for the assumed parameter values) in terms of prion biology. From sections 3.2 and 3.3, the system (2.4) always has a DFE (£/, V, P) = (0, ^,0), which attracts all solutions if 7 > /i + (3 * x0 and 1Z0 = ^fj^^ < 1. This is the only equilibrium for 7£0 < 1, but for Ho > 1 there is a unique EE ([/*, V*, P*), with P* = W* 4-xqU* and V* < A/7, as can be seen from (3.6). This equilibrium On the U^ graph, 10"6 < r/ < 10"3, 10~6 < u> < 10" and 50 < C/oo < 250. On the Poo graph, 10~6 < r\ < 10~2, 10~6 < a; < 10~4, and 20,000 < Poo 100,000.
is given explicitly by (3.8) in the case of no joining, and with joining it can be fou from the solution of a cubic (see Lemma 3.6). If 1Zo > 1, then this EE is loca asymptotically stable. Prom section 3.6, both increased u and increased rj cause U* to decrease. The change related to u indicates that as the total population of PrPSc has a grea effect on general incidence, the total number of polymers at the EE decreases. F the parameters used, if u> > 10~3, then the values of ([/*, V*, P*) are close to those the DFE, as seen in Figure 2 . The change related to 77 indicates that a higher rate polymer joining results in fewer total polymers at the EE. Increased u and increa 77 cause V* to increase. Hence the same biological changes cause both a decrease prpSc poivmers anci an increase in PrPc at the EE. Additionally, increased u and increased rj cause the equilibrium value P* of total PrPSc to decrease. If 77 increa then at the EE the mean polymer length ^ increases, with lnP* decreasing more slowly than In U* .
The effects on W* are more complicated. Increased a;, that is, increased depe dence of incidence on the total PrPs<r^>opulation, decreases W*. On the other han an increased rate of polymer joining has a variable effect on W*. Differing parame combinations can cause W* to either increase or decrease with a positive change T)\ see Figure 5 . That noted, it is also true that most viable parameter combinatio cause W* to decrease when 77 increases.
Recall that the form of TZo given in (3.2) is the same with either mass action or ou general incidence term, and with or without polymer joining. Despite the inabil of lj and 77 to affect disease persistence, however, each of these parameters has demonstrable effect on the steady-state values of £/, V, and P. Also, increasing clearly decreases the number of polymers of each possible length, with the maxim for u = 10~4 being about half the maximum for u = 0; see Figure 3 . From d
given by Rubenstein et al. [30] , the onset of symptoms of scrapie can be estima [14] to occur as U(t) reaches a critical value of 130 SAF/sq. From Figures 2 and 4 the inclusion of general incidence or joining may result in U* less than this criti value, while V* remains closer to its DFE value. Thus, if the effects of prion dise are caused by either an excess of PrPSc or a lack of PrPc [24, 29] , then changing the EE by increasing u or 77 may be enough to delay or prevent the onset of dise symptoms. 
